Login / Signup

Cost-Effectiveness of Dorsal Root Ganglion Stimulation or Spinal Cord Stimulation for Complex Regional Pain Syndrome.

Nagy A MekhailTimothy R DeerLawrence PoreePeter S StaatsAllen W BurtonAllison T ConnollyEdward KarstDiana S MehannyYoussef SawerisRobert M Levy
Published in: Neuromodulation : journal of the International Neuromodulation Society (2020)
DRG and SCS are cost-effective treatments for chronic pain secondary to CRPS-I and II compared to CMM. DRG accrued higher cost due to higher conversion from trial to permanent implant and shorter battery life, but DRG was the most beneficial therapy due to more patients receiving permanent implants and experiencing higher quality of life compared to SCS. New DRG technology has improved battery life, which we expect to make DRG more cost-effective compared to both CMM and SCS in the future.
Keyphrases
  • spinal cord
  • chronic pain
  • neuropathic pain
  • spinal cord injury
  • clinical trial
  • soft tissue
  • study protocol
  • randomized controlled trial
  • current status
  • phase ii
  • pain management
  • phase iii
  • cell therapy